糖化血红蛋白与糖尿病并慢性心衰相关性的研究进展
Research Progress on the Relationship between HbA1c and Diabetes Complicated with Chronic Heart Failure
DOI: 10.12677/ACM.2024.141161, PDF,   
作者: 迪达尔·依沙, 娜几娜·吾格提*：新疆医科大学第一附属医院心力衰竭科，新疆 乌鲁木齐
关键词: 糖尿病；慢性心衰；糖化血红蛋白；Diabetes； Chronic Heart Failure； HbA1c
摘要: 目前糖尿病合并慢性心衰患者发病率明显升高，并严重危害人类健康。评价糖尿病患者血糖控制水平的“金标准”是糖化血红蛋白，研究表明，糖化血红蛋白水平与糖尿病合并慢性心衰患者病情发生及发展有密切关系，测定糖化血红蛋白水平可以有效预测慢性心衰患者病情进展情况。现综述近几年聚焦于“糖化血红蛋白与糖尿病合并慢性心衰”关系的研究，拟为综合管理糖尿病合并慢性心衰患者提供临床指导。
Abstract: The incidence of diabetes mellitus combined with chronic heart failure has increased significantly and is a serious threat to human health. The “gold standard” for evaluating the level of glycemic control in diabetic patients is hemoglobin A1c, and studies have shown that hemoglobin A1c levels are closely related to the occurrence and progression of the disease in patients with diabetes melli-tus combined with chronic heart failure, and the measurement of hemoglobin levels can effectively predict the progression of the disease in patients with chronic heart failure. We review the recent studies focusing on the relationship between hemoglobin A1c and diabetes mellitus combined with chronic heart failure, with the aim of providing clinical guidance for the comprehensive manage-ment of patients with diabetes mellitus combined with chronic heart failure.
文章引用：迪达尔·依沙, 娜几娜·吾格提. 糖化血红蛋白与糖尿病并慢性心衰相关性的研究进展[J]. 临床医学进展, 2024, 14(1): 1117-1123. https://doi.org/10.12677/ACM.2024.141161

参考文献

[1] 中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10): 760-789.
[2] Bell, D.S.H. and Gon-calves, E. (2019) Heart Failure in the Patient with Diabetes: Epidemiology, Aetiology, Prognosis, Therapy and the Effect of Glucose-Lowering Medications. Diabetes, Obesity & Metabolism, 21, 1277-1290. [Google Scholar] [CrossRef] [PubMed]
[3] Koniari, I., Velissaris, D., Kounis, N.G., et al. (2022) Anti-Diabetic Ther-apy, Heart Failure and Oxidative Stress: An Update. Journal of Clinical Medicine, 11, Article 4660. [Google Scholar] [CrossRef] [PubMed]
[4] Dunlay, S.M., Killian, J.M., McCoy, R.G. and Redfield, M.M. (2022) Diabetes Mellitus in Advanced Heart Failure. Journal of Cardiac Failure, 28, 503-508. [Google Scholar] [CrossRef] [PubMed]
[5] Pazin-Filho, A., Kottgen, A., Bertoni, A.G., et al. (2008) HbA 1c as a Risk Factor for Heart Failure in Persons with Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetologia, 51, 2197-2204. [Google Scholar] [CrossRef] [PubMed]
[6] Roth, G.A., Mensah, G.A., Johnson, C.O., et al. (2020) Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study. Journal of the American College of Cardiology, 76, 2982-23021. [Google Scholar] [CrossRef] [PubMed]
[7] 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021, 36(6): 521-545.
[8] 中国心衰中心联盟, 苏州工业园区心血管健康研究院, 中国心血管健康联盟. 中国心衰中心工作报告(2021)——心力衰竭患者的诊疗现况[J]. 中国介入心脏病学杂志, 2022, 30(5): 328-336.
[9] Sun, H., Saeedi, P., Karuranga, S., et al. (2022) IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Research and Clinical Prac-tice, 183, Article ID: 109119. [Google Scholar] [CrossRef] [PubMed]
[10] He, J., Ogden, L.G., Bazzano, L.A., et al. (2001) Risk Factors for Congestive Heart Failure in US Men and Women: NHANES I Epidemiologic Fol-low-Up Study. Archives of Internal Medicine, 161, 996-1002. [Google Scholar] [CrossRef] [PubMed]
[11] Seferović, P.M., Petrie, M.C., Filippatos, G.S., et al. (2018) Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 20, 853-872. [Google Scholar] [CrossRef] [PubMed]
[12] Kannel, W.B., Hjortland, M. and Castelli, W.P. (1974) Role of Diabetes in Congestive Heart Failure: The Framingham Study. The American Journal of Cardiology, 34, 29-34. [Google Scholar] [CrossRef] [PubMed]
[13] Park, J.J. (2021) Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes. Diabetes & Metabolism Journal, 45, 146-157. [Google Scholar] [CrossRef] [PubMed]
[14] Sarma, S., Mentz, R.J., Kwasny, M.J., et al. (2013) As-sociation between Diabetes Mellitus and Post-Discharge Outcomes in Patients Hospitalized with Heart Failure: Findings from the EVEREST Trial. European Journal of Heart Failure, 15, 194-202. [Google Scholar] [CrossRef] [PubMed]
[15] Zhang, Y., Zhang, J., Butler, J., et al. (2017) Contemporary Epidemiol-ogy, Management, and Outcomes of Patients Hospitalized for Heart Failure in China: Results from the China Heart Fail-ure (China-HF) Registry. Journal of Cardiac Failure, 23, 868-875. [Google Scholar] [CrossRef] [PubMed]
[16] Nakamura, K., Miyoshi, T., Yoshida, M., et al. (2022) Patho-physiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus. International Journal of Molecular Sciences, 23, Article 3587. [Google Scholar] [CrossRef] [PubMed]
[17] Rubler, S., Dlugash, J., Yuceoglu, Y.Z., et al. (1972) New Type of Cardiomyopathy Associated with Diabetic Glomerulosclerosis. The American Journal of Cardiology, 30, 595-602. [Google Scholar] [CrossRef] [PubMed]
[18] Connelly, K.A., Kelly, D.J., Zhang, Y., et al. (2007) Function-al, Structural and Molecular Aspects of Diastolic Heart Failure in the Diabetic (mRen-2)27 Rat. Cardiovascular Research, 76, 280-291. [Google Scholar] [CrossRef] [PubMed]
[19] Lebeche, D., Davidoff, A.J. and Hajjar, R.J. (2008) Interplay between Impaired Calcium Regulation and Insulin Signaling Abnormalities in Diabetic Cardiomyopathy. Nature Clinical Practice Cardiovascular Medicine, 5, 715-724. [Google Scholar] [CrossRef] [PubMed]
[20] Huynh, K., Kiriazis, H., Du, X.J., et al. (2012) Coenzyme Q10 Attenu-ates Diastolic Dysfunction, Cardiomyocyte Hypertrophy and Cardiac Fibrosis in the db/db Mouse Model of Type 2 Dia-betes. Diabetologia, 55, 1544-1553. [Google Scholar] [CrossRef] [PubMed]
[21] Bugger, H. and Abel, E.D. (2014) Molecular Mechanisms of Di-abetic Cardiomyopathy. Diabetologia, 57, 660-671. [Google Scholar] [CrossRef] [PubMed]
[22] Huynh, K., Bernardo, B.C., McMullen, J.R., et al. (2014) Diabetic Cardiomyopathy: Mechanisms and New Treatment Strategies Targeting Antioxidant Signaling Pathways. Pharmacology & Therapeutics, 142, 375-415. [Google Scholar] [CrossRef] [PubMed]
[23] American Diabetes Association (2010) Standards of Medical Care in Diabetes—2010. Diabetes Care, 33, S11-S61. [Google Scholar] [CrossRef] 
[24] American Diabetes Association (2010) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 33, S62-S69. [Google Scholar] [CrossRef] 
[25] Selvin, E., Marinopoulos, S., Berkenblit, G., et al. (2004) Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus. Annals of Internal Medicine, 141, 421-431. [Google Scholar] [CrossRef] [PubMed]
[26] Shi, C., Wang, L.J., Hu, D.F., et al. (2010) Prevalence, Clinical Characteristics and Outcome in Patients with Chronic Heart Failure and Diabetes. Chinese Medical Journal, 123, 646-650. [Google Scholar] [CrossRef] 
[27] 陈春晓, 蔡丽蓉, 魏贤聪. 慢性心衰合并2型糖尿病患者HbA1c水平与心衰严重程度的相关性研究[J]. 黑龙江医药, 2021, 34(1): 14-17.
[28] Stratton, I.M., Adler, A.I., Neil, H.A., et al. (2000) Association of Glycaemia with Macrovascular and Microvascular Complications of Type 2 Diabetes (UKPDS 35): Prospective Observational Study. BMJ, 321, 405-412. [Google Scholar] [CrossRef] [PubMed]
[29] Aguilar, D., Bozkurt, B., Ramasubbu, K., et al. (2009) Relationship of Hemoglobin A1C and Mortality in Heart Failure Patients with Diabetes. Journal of the American College of Cardiol-ogy, 54, 422-428. [Google Scholar] [CrossRef] [PubMed]
[30] Gerstein, H.C., Miller, M.E., Byington, R.P., et al. (2008) Effects of Intensive Glucose Lowering in Type 2 Diabetes. The New England Journal of Medicine, 358, 2545-2559. [Google Scholar] [CrossRef] 
[31] Eshaghian, S., Horwich, T.B. and Fonarow, G.C. (2006) An Unex-pected Inverse Relationship between HbA1c Levels and Mortality in Patients with Diabetes and Advanced Systolic Heart Failure. American Heart Journal, 151, 91.e1-91.e6. [Google Scholar] [CrossRef] [PubMed]
[32] Blecker, S., Park, H. and Katz, S.D. (2016) Association of HbA1c with Hospitalization and Mortality among Patients with Heart Failure and Diabetes. BMC Cardiovascular Disorders, 16, Article No. 99. [Google Scholar] [CrossRef] [PubMed]
[33] Gerstein, H.C., Swedberg, K., Carlsson, J., et al. (2008) The He-moglobin A1c Level as a Progressive Risk Factor for Cardiovascular Death, Hospitalization for Heart Failure, or Death in Patients with Chronic Heart Failure: An Analysis of the Candesartan in Heart Failure: Assessment of Reduction in Mor-tality and Morbidity (CHARM) Program. Archives of Internal Medicine, 168, 1699-1704. [Google Scholar] [CrossRef] [PubMed]
[34] Parry, H.M., Deshmukh, H., Levin, D., et al. (2015) Both High and Low HbA1c Predict Incident Heart Failure in Type 2 Diabetes Mellitus. Circulation Heart failure, 8, 236-242. [Google Scholar] [CrossRef] 
[35] Gu, J., Pan, J.A., Fan, Y.Q., et al. (2018) Prognostic Impact of HbA1c Variability on Long-Term Outcomes in Patients with Heart Failure and Type 2 Diabetes Mellitus. Cardiovascular Diabetology, 17, Article No. 96. [Google Scholar] [CrossRef] [PubMed]
[36] Segar, M.W., Patel, K.V., Vaduganathan, M., et al. (2020) Asso-ciation of Long-Term Change and Variability in Glycemia with Risk of Incident Heart Failure among Patients with Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial. Diabetes Care, 43, 1920-1928. [Google Scholar] [CrossRef] [PubMed]
[37] Wang, P., Huang, R., Lu, S., et al. (2015) HbA1c below 7% as the Goal of Glucose Control Fails to Maximize the Cardiovascular Benefits: A Meta-Analysis. Cardiovascular Diabetology, 14, Ar-ticle No. 124. [Google Scholar] [CrossRef] [PubMed]
[38] Bahtiyar, G., Gutterman, D. and Lebovitz, H. (2016) Heart Failure: A Major Cardiovascular Complication of Diabetes Mellitus. Current Diabetes Reports, 16, 116. [Google Scholar] [CrossRef] [PubMed]
[39] 中华医学会内分泌学分会. 中国成人2型糖尿病合并心肾疾病患者降糖药物临床应用专家共识[J]. 中华糖尿病杂志, 2020, 12(6): 369-381.

为你推荐